Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene

Details for Australian Patent Application No. 2009296395 (hide)

Owner Alnylam Pharmaceuticals, Inc. Hinkle, G.

Inventors Hinkle, Gregory; De Fougerolles, Antonin; Novobrantseva, Tatiana

Agent FB Rice

Pub. Number AU-A-2009296395

PCT Pub. Number WO2010/036962

Priority 61/100,195 25.09.08 US

Filing date 25 September 2009

Wipo publication date 1 April 2010

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

Event Publications

21 April 2011 PCT application entered the National Phase

  PCT publication WO2010/036962 Priority application(s): WO2010/036962

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009296396-Organic tandem solar cells

2009296394-Spinal cord injury, inflammation, and immune-disease: local controlled release of therapeutic agents